These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Aug. 27 through Sept. 2, 2026. Source: VerityData

Increases in Holdings

Immatics $(IMTX)$ Perceptive Advisors raised its stake in the clinical-stage cancer immunotherapy company to 11,418,016 shares. Perceptive Advisors did so through the purchase of 863,060 Immatics shares on Aug. 26 at a price of $8.69 per share pursuant to an underwritten public offering.

Following the latest purchase, Perceptive Advisors owns a 7.6% stake in Immatics' outstanding stock. Shares of Immatics have lost roughly 9.1% of their value since the beginning of this year.

Allot Communications $(ALLT)$ QVT Financial raised its stake in the network intelligence and security provider to 5,734,812 shares. QVT Financial did so through the purchase of 136,519 Allot Communications shares from Aug. 24 through Aug. 26 at per share prices ranging from $7.52 to $7.73.

Following the latest purchases, QVT Financial owns an 11.7% stake in Allot Communications' outstanding stock. Shares of Allot Communications have lost roughly 22.8% of their value since the beginning of this year.

Decreases in Holdings

Genco Shipping & Trading $(GNK)$ Diana Shipping lowered its stake in the dry-bulk shipping company to 4,416,292 shares. Diana Shipping did so through the sale of 1,848,256 Genco Shipping & Trading shares from Aug. 21 through Aug. 25 at per share prices ranging from $26.29 to $27.50.

Following the latest sales, Diana Shipping continues to own a 10.1% stake in Genco Shipping & Trading's outstanding stock. Shares of Genco Shipping & Trading have gained approximately 46.4% in value since the beginning of this year.

Aurinia Pharmaceuticals $(AUPH)$ ILJIN SNT lowered its stake in the maker of lupus treatment Lupkynis to 5,911,237 shares. ILJIN SNT did so through the sale of 640,295 Aurinia Pharmaceuticals shares from June 30 through Aug. 20 at per share prices ranging from $15.47 to $17.27.

Following the latest sales, ILJIN SNT and its affiliates continue to own a 4.4% stake in Aurinia Pharmaceuticals' outstanding stock, placing ILJIN SNT below the 5% threshold that would require it to report further sales. Shares of Aurinia Pharmaceuticals have gained approximately 6.1% in value since the beginning of this year.

Turtle Beach $(TBCH)$ DC VGA lowered its stake in the gaming headset and accessories maker to 674,706 shares. DC VGA did so through the sale of 1,100,735 Turtle Beach shares from Aug. 13 through Aug. 27 at per share prices ranging from $12.85 to $13.31.

Following the latest sales, DC VGA continues to own a 3.8% stake in Turtle Beach's outstanding stock, placing DC VGA below the 5% threshold that would require it to report further sales. Shares of Turtle Beach have lost roughly 11.1% of their value since the beginning of this year.

Email: editors@barrons.com